Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02908932 · ClinicalTrials.gov registry record · NA
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 555
- Enrollment target
NCT02908932 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 555 participants.
The verdict
NCT02908932, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 555 participants
- Enrollment target
Study Summary
The goal of this study is to determine if supplementation with krill oil concentrate containing the phospholipid-bound omega-3 fatty acids improves performance on specific cognitive tests that underlie key elements in U.S. Army Infantry Basic Officer Leaders Course (IBOLC) and in Ranger School (Training) at Fort Benning, Georgia (GA).
Interventions
- DIETARY_SUPPLEMENT Placebo supplement
- DIETARY_SUPPLEMENT Phospholipid-bound omega-3 supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 555 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02908932
The ClinicalTrials.gov registry entry for NCT02908932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 555 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo supplement is the first listed.
NCT02908932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02908932 about?
NCT02908932 is a clinical study titled "Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's". The goal of this study is to determine if supplementation with krill oil concentrate containing the phospholipid-bound omega-3 fatty acids improves performance on specific cognitive tests that underlie key elements in U.S. Army Infantry Basic Officer Leaders Course (IBOLC) and in Ranger School (Trai...
What is the current status of trial NCT02908932?
This trial is currently completed. It is a NA study. The enrollment target is 555 participants. The study started on 2016-08. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02908932?
The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Phospholipid-bound omega-3 supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02908932?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.